| Novartis Pharma Schweiz AG - Optaflu, Injektionssuspension | | 58271 | | 03 | | Optaflu | | Injektionssuspension | | J07BB02 | | Influenza, Inactivated, Split Virus Or Surface Antigen | | 10.09.2015 | | |
| | Composition | | haemagglutininum influenzae A (H1N1) (Virus-Stamm A/California/7/2009 (H1N1)-like: A/Brisbane/10/2010) 15 µg, haemagglutininum influenzae A (H3N2) (Virus-Stamm A/Switzerland/9715293/2013 (H3N2)-like: A/South Australia/55/2014) 15 µg, haemagglutininum influenzae B (Virus-Stamm B/Phuket/3073/2013-like: B/Utah/9/2014) 15 µg, natrii chloridum, kalii chloridum, magnesii chloridum hexahydricum, dinatrii phosphas dihydricus, kalii dihydrogenophosphas, aqua ad iniectabilia, q.s. ad suspensionem pro 0.5 ml. | | Packungsbestandteile | | Injection suspension | | | | | | Active Agent | Dose |
|---|
| Haemagglutininum Influenzae a (H1N1) (Virus-Stamm A/california/7/2009 (H1N1)-Like: A/brisbane/10/2010) | 15 µg | | Haemagglutininum Influenzae a (H3N2) (Virus-Stamm A/switzerland/9715293/2013 (H3N2)-Like: A/south Australia/55/2014) | 15 µg | | Haemagglutininum Influenzae b (Virus-Stamm B/phuket/3073/2013-Like: B/utah/9/2014) | 15 µg |
| | | | Inactive agents |
|---|
| Disodium Phosphate Dihydrate | | Potassium Chloride | | Potassium Dihydrogenophosphate | | Magnesium Chloride Hexahydrate | | Sodium Chloride |
|
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| No entries have been found. |
|
|
